Our scientific expertise, experience across a wide range of therapeutics and regions, multi-continent foundation, and commitment to quality provide complete analytic solutions for protein biologics and cell and gene therapeutics throughout products’ development and regulatory life cycles—from discovery to market.
Discovery – Pre-clinical
Biologic Candidate Evaluation, Optimization and Selection into IND
Phase I – Phase III
Release, Clinical Data and Characterization Packages for Accelerating Phase I-III Programs through BLA
Registration – Market
Commercial-Stage Comparability Testing by Qualified Advanced Methods
Enabled by state-of-the-art technology, ProtaGene offers an extensive range of analytical capabilities to support your biotherapeutic or gene & cell therapy projects.
Perhaps you need support to overcome a specific challenge, or maybe you’re looking for a close partnership throughout your product’s entire life cycle. ProtaGene’s CMC experts are here to help.
Whether you are looking to learn more about our platforms or get a project started, contact our team today to discover how ProtaGene can support your development programs.Contact Us